The fastrack mentioned is for regenerative medicine (stem cells). Note that the Stratagraft phase III study started only this year in May and is planned to conclude January 2019. They have restricted the burns sites to limbs and torso. As we know, BTM has established its value beyond these areas in dealing with burns to the skull and wounds to the neck.
BTM in the UK??, page-7
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.04 |
Change
-0.030(1.45%) |
Mkt cap ! $1.409B | |||
| Open | High | Low | Value | Volume |
| $2.09 | $2.11 | $2.03 | $1.727M | 838.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 299194 | $2.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.04 | 1559 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |